[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366372-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366372-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","synchronous-triple-negative-breast-cancer-rectal-adenocarcinoma-and-chemotherapy-induced-hepatitis-b-virus-reactivation-case-report-and-review-of-the-literature","Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation - Case report and review of the literature","","Managing synchronous multiple primary cancers is challenging, particularly when chemotherapy triggers severe complications such as hepatitis B virus (HBV) reactivation. This case report describes a 55-year-old Arab woman with a rapidly growing triple-negative breast cancer carrying a BRCA1/BRCA2 mutation, whose neoadjuvant chemotherapy was stopped early after transaminitis and rising HBV DNA confirmed HBV reactivation. Prompt entecavir therapy followed by surgery for both distinct primaries resulted in recovery, no recurrence at 3 years, and emphasizes routine HBV screening, vigilant monitoring, and multidisciplinary care.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/synchronous-triple-negative-breast-cancer-rectal-adenocarcinoma-and-chemotherapy-induced-hepatitis-b-virus-reactivation-case-report-and-review-of-the-literature/366372/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/synchronous-triple-negative-breast-cancer-rectal-adenocarcinoma-and-chemotherapy-induced-hepatitis-b-virus-reactivation-case-report-and-review-of-the-literature/366372.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why was chemotherapy stopped in the presented case?","Question",{"text":63,"@type":64},"Neoadjuvant chemotherapy was discontinued early due to severe liver inflammation (transaminitis) and a sharp increase in hepatitis B virus levels, confirming HBV reactivation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What treatment was started to address HBV reactivation?",{"text":68,"@type":64},"Antiviral therapy with entecavir was promptly initiated after confirmation of HBV reactivation.",{"name":70,"@type":61,"acceptedAnswer":71},"How were both cancers managed and what was the outcome?",{"text":72,"@type":64},"The patient underwent successful surgeries for a right modified radical mastectomy and rectal resection with colostomy; pathology confirmed two distinct primary tumors. After adjuvant radiation, she remained healthy and disease-free at 3-year follow-up.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366372,1790955657,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Al‑Bitar et al. Journal of Medical Case Reports (2025) 19:382  \n[https://doi.org/10.1](https://doi.org/10.1) 186/s13256‑025‑05423‑8  \nJournal of Medical Case Reports  \n CASE REPORT Open Access  \nSynchronous triple‑negative    \nbreast cancer, rectal adenocarcinoma, and chemotherapy‑induced hepatitis B virus reactivation: a case report and review of the literature  \nAhmad Al-Bitar1* , IsraaTellawi1, Hazem Kamil 1, Dana Al-Masalma1, Karam Jeji2 and Souheb Al-mahasna3  \nAbstract  \nBackground The occurrence of multiple primary cancers is increasing, largely due to better diagnostic tools and longer patient survival. However, managing these cases can be complex, especially when treatments such as chemotherapy lead to complications such as hepatitis B virus (HBV) reactivation, which carries a significant risk of severe illness and death.  \nCase presentation We present the case of a 55-year-old Arab woman diagnosed with a rapidly growing triplenegative breast cancer, found to have a BRCA1/BRCA2 mutation. She began neoadjuvant chemotherapy, but the treatment was stopped early due to severe liver inflammation (transaminitis) and a sharp increase in hepatitis B virus levels, confirming hepatitis B virus reactivation. Antiviral therapy with entecavir was promptly started. Later, the patient developed rectal bleeding, leading to the diagnosis of a mid-rectal invasive adenocarcinoma. She underwent successful surgeries for both cancers: a right modified radical mastectomy and a rectal resection with colostomy. Pathology confirmed two distinct primary tumors. Despite initial concerns due to a positron emission tomography scan, subsequent biopsies showed no recurrence. The patient completed adjuvant radiation and, at a 3-year follow-up, remains healthy and disease-free.  \nConclusion This case highlights the intricate challenges of managing synchronous primary cancers and the lifethreatening risk of hepatitis B virus reactivation during chemotherapy. It strongly emphasizes the need for routine hepatitis B virus screening before chemotherapy, careful monitoring of liver function and viral loads, and the immediate availability of antiviral treatment. A collaborative, multidisciplinary approach is essential for prioritizing treatments effectively and achieving good outcomes in patients with such complex cancer presentations.  \nKeywords Multiple Primary Cancers (MPCs), Breast Cancer, Rectal Adenocarcinoma, Reactivation of Hepatitis B  \n*Correspondence: Ahmad Al-Bitar  \n[dr.ahmad.al.bitar@gmail.com](dr.ahmad.al.bitar@gmail.com); [ahmad.albitar@damascusuniversity.edu.sy](ahmad.albitar@damascusuniversity.edu.sy)  \n1 Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic  \n2 Department of Oncology, Ibn Al-Nafees Hospital, Damascus, Syrian Arab Republic  \n3 Department of General Surgery, Al-Mouwasat University Hospital, Damascus, Syrian Arab Republic  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](htt","cbCaiuGFesINkxpF","https://ap.wps.com/l/cbCaiuGFesINkxpF","pdf",1806819,"English","# Case presentation\n## Background\n## Conclusion","[{\"question\":\"Why was chemotherapy stopped in the presented case?\",\"answer\":\"Neoadjuvant chemotherapy was discontinued early due to severe liver inflammation (transaminitis) and a sharp increase in hepatitis B virus levels, confirming HBV reactivation.\"},{\"question\":\"What treatment was started to address HBV reactivation?\",\"answer\":\"Antiviral therapy with entecavir was promptly initiated after confirmation of HBV reactivation.\"},{\"question\":\"How were both cancers managed and what was the outcome?\",\"answer\":\"The patient underwent successful surgeries for a right modified radical mastectomy and rectal resection with colostomy; pathology confirmed two distinct primary tumors. After adjuvant radiation, she remained healthy and disease-free at 3-year follow-up.\"}]","Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation - Case report and review of the literature | PDF",1790165035,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f66ae99ce689aa454150894931ef0c5.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2a61e83dbb5238186c1f30f3a16d2a1.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2340080fadbc1cc9184b046cb85f7652.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdd9b869542f8071aafa4a2a03227550.webp",980,1301]